GlassScriptPhysician profile
Sheldon Y Freeberg
NPI 1639344310
$12,994.90
in general payments reported to CMS, 2019-2025
25 companies · $2,076 in 2025
The $2,076 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,117 · 2020: $875 · 2021: $1,380 · 2022: $1,591 · 2023: $2,686 · 2024: $3,270 · 2025: $2,076.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,815 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,513 · Travel and Lodging: $705.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,815.19 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,512.50 |
| Travel and Lodging | $704.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,833.07 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| Medtronic Vascular, INC. | $1,339.54 | 2019-2020 | |
| Abbott Laboratories | $1,310.86 | 2019-2025 | Mitraclip, Amplatzer Talisman, Perclose Prostyle |
| Boston Scientific Corporation | $432.45 | 2019-2024 | Wolverine Coronary Cutting Balloon, Eluvia, Ekosonic |
| Shockwave Medical, INC | $352.29 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $308.26 | 2023-2025 | Lifevest |
| Edwards Lifesciences Corporation | $239.06 | 2024-2025 | Sapien 3 Ultra Resilia |
| Heartflow, INC. | $141.66 | 2021 | |
| Siemens Medical Solutions USA, INC. | $129.11 | 2020-2023 | Artis Icono Biplane |
| Bard Peripheral Vascular, INC. | $129.07 | 2023 | Venovo |
| E.R. Squibb & Sons, L.L.C. | $123.76 | 2022-2024 | Camzyos |
| Getinge USA Sales, LLC | $121.43 | 2025 | Heartstring III Proximal Seal |
| Cardiovascular Systems INC. | $92.20 | 2019-2023 | Diamondback Coronary |
| Sanofi-Aventis U.S. LLC | $85.02 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $57.11 | 2022-2024 | Verquvo |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $48.95 | 2019-2024 | |
| Abiomed | $48.58 | 2019-2025 | |
| Amgen INC. | $43.26 | 2019-2024 | Repatha |
| Teleflex LLC | $40.78 | 2019 | |
| Acist Medical Systems, INC. | $24.54 | 2019 | |
| Irhythm Technologies, INC. | $21.49 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.56 | 2023 | Jardiance |
| Biosense Webster, INC. | $19.90 | 2020 | |
| Pfizer INC. | $18.80 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $13.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheldon Freeberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.